Based on data from the World Health Oraganisation and Deloitte research, the value of expected health benefits arising from clonical research conducted in Thailand in 2015 is ฿ 10.5 billion
All costs and benefits arising from clinical research in Thailand in 2015 were compiled and compared through a cost benefit analysis. Compare to total costs of ฿10.4 billion, total benefits sum to ฿30.0 billion (USD 0.9 billion), with a benefit-cost ratio of 2.9:1.This means that for every ฿1 spent on clinical trials in Thailand in 2015, the return was ฿2.9.
Phone : (02) 619-0232-6
Fax : (02) 619-0237
Email : [email protected]